Gastroenterology

Revive Research Institute’s team of experienced Gastroenterologist along with research staff are working tirelessly to make new and improved therapeutic interventions accessible to you and countless others. Through our work in Gastroenterology research, we aim to impact the standard of care and treatments available for GI indications.

Eosinophilic Esophagitis

Do you feel difficulty in swallowing?
Eosinophilic Esophagitis is caused by the presence of a large number of eosinophils (white blood cells) in the esophagus, leading to scarring of esophagus.

If it is not treated, symptoms and inflammation can progress leading to irreversible damage to your esophagus. There are currently no therapies approved by the US Food and D  rug Administration (FDA) for Eosinophilic Esophagitis. Revive Research Institute is conducting Phase 2 Gastroenterology Research to evaluate efficacy, safety and tolerability of the study drug in adults with active Eosinophilic Esophagitis (EoE).

Age

18-75 years

Gender

Males and females

Condition

Eosinophilic Esophagitis

Current Status

Recruiting

Colorectal Cancer Screening

Are you suffering from Colorectal Cancer?
Colorectal cancer is the second leading cause of death among adults with cancer, but it doesn’t have to be. If found early, it’s one of the most preventable and treatable cancers.

Cancer screening tests, such as colonoscopy, can prevent colorectal cancer or find it early, when treatment works best. Yet 1 in 3 adults are not getting the screenings tests that could save their lives. A simple blood test that looks for early signs of colorectal cancer may make it easier for some people to be screened. Revive Research Institute is conducting clinical research to see if a simple blood test can detect colorectal cancer early, when it is easier to treat and possible to cure.

Age

45-84 years

Gender

Males and Females

Condition

Colorectal Cancer

Current Status

Recruiting

Crohn’s Disease

Lets Wipe Out Crohn’s
Are you tired of going to the washroom every other hour?
Revive Research Institute is conducting a Phase I-IV Clinical Trials that might be beneficial in managing your symptoms.

Our purpose of this study is to test the safety and efficacy of our drug for treating Crohn’s disease. Our experienced Gastrologist is conducting this study in Michigan along with a team of trained Gastroenterology Research staff.

Age

18 - 80 years of age

Gender

Slightly more common in females than males

Condition

Crohn's Disease

Current Status

Recruiting

Ulcerative Colitis

Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. At Revive Research Institute, our experienced gastroenterology research staff and some of the best Gastroenterologist near you are conducting Phase 3 research studies for Ulcerative Colitis patients.

The goal of the study is to determine the safety and efficacy of investigational medications when used in conjunction with routine therapy to help persons with Ulcerative Colitis heal.

Age

18 years and above

Gender

Male and Female (Non Pregnant)

Condition

Ulcerative Colitis

Current Status

Recruiting

GERD

Revive Research Institute is conducting Gastroenterology Clinical Research, including a Phase 2 GERD research study to help Gastroenterologist understand if an investigational drug could help people who are still unhealed even after receiving the standard treatment.

The goal of the trial is to see if using the investigational medication in combination with routine care can reduce heartburn, acid reflux and similar symptoms.

Age

18-75 years

Gender

Male and Female

Condition

Reflux Esophagitis

Current Status

Recruiting

Chronic Idiopathic Constipation

Chronic constipation is a common gastrointestinal ailment for which there is currently no effective treatment that has minimal side effects and optimal tolerability.

Researchers and Gastrologists at Revive Research Institute are making progress on a Clinical Trial for an experimental oral medication that may be able to help treat chronic constipation. The purpose of the clinical trial is to assess the drug’s safety and efficacy. To determine the success of the oral intervention and a potential treatment for constipation, our healthcare staff will continue monitoring your health and symptoms throughout the study.

Age

22 years or older

Gender

Male & Female

Condition

Chronic Idiopathic Constipation

Current Status

Not Recruiting

Clostridium Difficile Infection (CDI)

Every year, approximately half a million Americans are affected by Clostridium Difficile-related disorders, generally known as deadly diarrhea. We are conducting clinical trials on an investigational medication that may be able to help treat this condition.

All participants will receive study-related care from experienced Gastrologists and research staff. If you qualify and decide to participate, you will receive study-related care and treatment free of cost to both you and your insurance.

Age

18 years or older

Gender

Male and Female

Condition

Clostridium Difficile Infection

Current Status

Not Recruiting